Globus Medical plans to buy spinal cord stimulation company Nevro for about $250 million, the companies announced on Thursday. Globus will pay $5.85 per share in an all-cash purchase, a 27% ...

22, 2015 /PRNewswire/ -- Nevro Corp. (NYSE ... for the Senza spinal cord stimulation (SCS) system. According to the approvable letter, approval of the PMA is subject to satisfaction of ...

Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its neuromodulation platforms for treating chronic pain. The all-cash deal comes ...

Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS ... and a mobile charger. The company generates the majority of its revenue in the United States.

Nevro said revenue is higher primarily due to the effect of greater-than-anticipated spinal cord stimulation device replacement procedures in the fourth quarter of 2024. Cash, cash equivalents and ...

The firm believes Globus gains access to a few assets that are more complimentary than neuromodulation, and it also thinks that if the company can use Nevro’s pain stimulation channel to sell ...